Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Li Hsun Chang (Contributor)
Jing-Ping Liou (Creator)
Mei-Jung Lai (Contributor)
Chao-Di Chang (Contributor)
Huang Ju Tu (Contributor)
Min Wu Chao (Contributor)
Shiow-Lin Pan (Contributor)
Yi Ying Chen (Creator)
Che Ming Teng (Contributor)

Dataset

Description

Table S1. IC50 of MPT0E028 and SAHA in pancreatic cell lines. AsPC-1, PANC-1, and BxPC-3 cells were treated with different concentrations of MPT0E028 or SAHA for 72â h. IC50 (the half maximal inhibitory concentration) was determined by MTT assay. (DOCX 12 kb)

Date made available	2019
Publisher	Figshare

DOI
10.6084/m9.figshare.8202902.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. W., Chang, L. H., Tu, H. J., Chang, C. D., Lai, M. J., Chen, Y. Y., Liou, J. P., Teng, C. M. & Pan, S. L., May 29 2019, In: Clinical Epigenetics. 11, 1, p. 85 85.
Research output: Contribution to journal › Article › peer-review

Open Access
28 Citations (Scopus)

Cite this

Chang, L. (Contributor), Liou, J. (Creator), Lai, M. (Contributor), Chang, C. (Contributor), Tu, H. (Contributor), Chao, M. (Contributor), Pan, S. (Contributor), Chen, Y. (Creator), Teng, C. (Contributor) (2019). Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Figshare. 10.6084/m9.figshare.8202902.v1

Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Description

DOI

Access Dataset

Research output

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Cite this